Ethyl 2-(tert-butoxycarbonylamino)-1,3-benzothiazole-6-carboxylate

Brantley, E., Trapani, V., Alley, M. C., Hose, C. D., Bradshaw, T. D., Stevens, M. F. G., Sausville, E. A. & Stinson, S. F. (2004). Drug Metab. Dispos., 32, 1392–1401. Caleta, I., Kralj, M., Marjanovic, M., Bertosa, B., Tomic, S., Pavlovic, G., Pavelic, K. & Karminski-Zamola, G. (2009). J. Med. Chem. 52, 1744–1756. Higashi, T. (2000). NUMABS. Rigaku Corporation, Tokyo, Japan. Lynch, D. E. (2002). Acta Cryst. E58, o1139–o1141. Matkovic-Calogovic, D., Popovic, Z., Tralic-Kulenovic, V., Racane, L. & Karminski-Zamola, G. (2003). Acta Cryst. C59, o190–o191. McArdle, P. (1995). J. Appl. Cryst. 28, 65. Mortimer, C. G., Wells, G., Crochard, J., Stone, E. L., Bradshaw, T. D., Stevens, M. F. G. & Westwell, A. D. (2006). J. Med. Chem. 49, 179–185. Palmer, P. J., Trigg, R. B. & Warrington, J. V. (1971). J. Med. Chem. 14, 248–251. Rigaku (2007). CrystalClear. Rigaku Inc., Tokyo, Japan. Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. Spek, A. L. (2009). Acta Cryst. D65, 148–155. organic compounds